Suppr超能文献

[常规与中等剂量分割肺癌放射治疗的疗效]

[Effectiveness of the radiation therapy of lung cancer with conventional and median dosage fractionation].

作者信息

Strashinin A I, Ivanova L V, Tereshchenko O I

出版信息

Med Radiol (Mosk). 1985 Aug;30(8):22-4.

PMID:4033385
Abstract

A total of 202 patients were studied: 100 patients received radiotherapy of a primary tumor under conditions of mean fractionation and 102 under conditions of common fractionation. In common fractionation a single focal dose was 2 Gy, 5 times a week, a summary dose 50-60 Gy. In mean fractionation a single focal dose was 3 Gy, 3 times a week for 6 week up to a sum of 54 Gy which was equivalent to 60 Gy in common fractionation. In mean fraction 58 patients received radiotherapy only, 42 radiotherapy with adjuvant chemotherapy. In common fractionation the patients' 1,3 and 5-year survival rates for the control group were 52.8, 14.4 and 10.2% respectively. Under conditions of mean fractionation the 3-year survival rate was 14.2%, i. e. similar to that in the control group. In chemoradiotherapy the 3-year survival rate was 12.4% that might be due to the fact that in spite of Stage III these patients' condition was grave. Pulmonary radiation reaction established by x-ray within 4-6 mos. after the termination of therapy with mean fractionation were marked in 63 of 81 patients, whereas in common fractionation in 30 of 90 patients only.

摘要

共研究了202例患者:100例患者在平均分割条件下接受原发性肿瘤放疗,102例在常规分割条件下接受放疗。在常规分割中,单次局部剂量为2Gy,每周5次,总剂量为50 - 60Gy。在平均分割中,单次局部剂量为3Gy,每周3次,共6周,总剂量达54Gy,相当于常规分割中的60Gy。在平均分割中,58例患者仅接受放疗,42例接受放疗联合辅助化疗。在常规分割中,对照组患者的1年、3年和5年生存率分别为52.8%、14.4%和10.2%。在平均分割条件下,3年生存率为14.2%,即与对照组相似。在放化疗中,3年生存率为12.4%,这可能是由于尽管处于III期,但这些患者的病情严重。在平均分割放疗结束后4 - 6个月内,通过X光检查确定的肺部放射反应在81例患者中的63例中较为明显,而在常规分割中,仅90例患者中的30例出现明显反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验